INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2006

Oral glucosamine sulphate yielded peak human serum glucosamine levels of 1.9 to 11.5 micromol/l, far below concentrations often used in in vitro studies.

Eighteen subjects with osteoarthritis were administered 1,500 mg of commercial glucosamine sulphate after an overnight fast, with serum collected over 3 hours (and up to 8 hours in two subjects). Baseline serum glucosamine was below the 0.5 mumol/l detection limit in all subjects. After ingestion, glucosamine was detected in 17 of 18 subjects, rising at 30-45 minutes to a maximum at 90-180 minutes with a range of 1.9-11.5 micromol/l (0.34-2 microg/ml). The authors note this peak concentration is far lower than levels claimed to have in vitro effects.

Study type
Pharmacokinetic intervention study
Who was studied
18 subjects with osteoarthritis
What was measured
Human serum and urine glucosamine concentrations

THE PAPER

Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.

Biggee BA, Blinn CM, McAlindon TE, Nuite M, Silbert JE. Ann Rheum Dis, 2006.

PubMed 16079170 ↗DOI 10.1136/ard.2005.036368 ↗

Bones & musclesOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.